Skip To Main Content
Michael D. Kinnaman on Muck Rack

Michael D. Kinnaman

Alva, New York
As seen in: Nature, BioRxiv
Medical Director @ Regeneron. Oncology Drug Development. Former Pediatric Sarcoma Specialist @ Sloan Kettering. Proud Michigan Wolverine. Cursed sports fan
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Michael D.

Contact Michael D., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Prior therapy defines mutation profiles in childhood cancer at relapse

|
By Mehdi Layeghifard, Marcos Díaz-Gay, Erik Bergström, Mathepan Mahendralingam, Nicholas Light, Sasha Blay, Joshua Nash, Nathaniel Anderson, Jessica Au, Scott Davidson, S. Islam, Azhar Khandekar, Burcak Otlu, Ledia Brunga, Rawan Hammad, Nirav Thacker, Noemi Fuentes-Bolanos, Marie Wong-Erasmus, Max Levine, Katherine Miller Verified, Neerav Shukla, Michael D. Kinnaman, Dominik Glodzik, Carol Portwine, Mariam Mikhail, Conrad V. Fernandez, Laura Wheaton, Gunes Gundem, Andrew Kung, Uri Tabori, Chelsea Mayoh, Elli Papaemmanuil, Mark Cowley, David Malkin, Anita Villani, Ludmil B. Alexandrov, Adam Shlien, Pedro L. Ballester, Timmy Wen, Syed Kashif Daud, Lisa-Monique Edward, Shimaa Nassif, Tara Feltham, Sabrina Millson, Alexandra P. Zorzi
| Nature Verified
Abstract Children with cancer develop many short- and long-term side-effects of treatment1, but the amount of DNA damage associated with chemotherapy exposure is unclear2. Here we used mutational signatures to measure this damage using whole-genome-sequenced tumours from a multi-institutional cohort for which therapy dose and total exposure were uniformly collected3,4,5.
Open in Who Shared Issue with article?

Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcoma

|
By Michael D. Kinnaman, Simone Zaccaria, Alvin P. Makohon-Moore, Brian Arnold
| BioRxiv
Thank you for your interest in spreading the word about bioRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. Message Subject (Your Name) has forwarded a page to you from bioRxiv Message Body (Your Name) thought you would like to see this page from the bioRxiv website.
Open in Who Shared View Duplicates (695) Issue with article?

Abstract B70: Clonal evolution of chemotherapy-resistant rhabdomyosarcoma via multifocal genomic analysis of pretreatment and treatment-resistant autopsy specimens

|
By Alvin P. Makohon-Moore, Nancy Bouvier, Dominik Glodzik, Michael D. Kinnaman
| cancerres.aacrjournals.org
Poster Presentations - Proffered Abstracts Michael D.
Open in Who Shared Issue with article?
See all 3 articles